Patients are typically responsible for any deductibles, copays, or additional services not covered by insurance
Patients with pacemakers often have arrhythmias, heart failure, or coronary artery diseaseconditions that may affect how GLP-1 therapy impacts your cardiovascular system
Mov Disord 29(12):15511555
Roughly half of the participants lost 15% of their weight or more
45 Interestingly, overall proportion of patients experiencing at least 1 adverse event was similar across treatment groups
[1] [2] As a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, Zepbound works by mimicking naturally occurring incretin hormones that regulate appetite, food intake, and glucose metabolism, though the exact mechanism for weight loss is not fully understood